CG
MDLN

Carlyle Group’s Medline Inc MDLN Stock Holding History

Carlyle Group’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.33B Sell
187,083,713
-28,219,323
-13% -$1.25B 78.4% 1
2025
Q4 		$9.04B Buy
+215,303,036
New +$9.09B 66.65% 1

Other funds holding MDLN

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Carlyle Group's MDLN Position: Q1 2026 in Review

Carlyle Group reduced its Medline Inc (MDLN) stake by 13% in Q1 2026, selling an estimated $1.25B and leaving 187,083,713 shares worth $8.33B. The position accounts for 78.4% of the portfolio, ranked #1.

Carlyle Group first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. The position peaked at $9.04B in Q4 2025. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • Carlyle Group held 187,083,713 shares of Medline Inc worth $8.33B as of Q1 2026.
  • Carlyle Group sold 28,219,323 Medline Inc shares in Q1 2026, an estimated $1.25B.
  • Medline Inc made up 78.4% of Carlyle Group's portfolio in Q1 2026, its #1 holding.
  • Carlyle Group first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
  • Carlyle Group's Medline Inc position peaked at $9.04B in Q4 2025.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Carlyle Group's 13F filing for Q1 2026, filed 8 May 2026.